Funding · Healthcare & Life Sciences

CARPL.ai raises $10 Mn in Series A funding

By Startup Enthusiast · 23 July 2026

What they do

CARPL.ai is a healthtech SaaS platform that helps hospitals deploy and manage multiple medical imaging AI applications

It raised $10 Mn (about ₹96 Cr) in Series A funding led by IFC, with participation from Stellaris Venture Partners

The company plans to use the funds for global expansion and product development, and to expand beyond radiology into pathology and genomics

CARPL.ai raised $10 Mn (about ₹96 Cr) in a Series A funding round.
The round was led by International Finance Corporation (IFC), the private sector arm of the World Bank Group.
Existing investor Stellaris Venture Partners also participated, along with undisclosed investors.
The company will use the funds for product development, expanding sales and delivery teams globally, and strengthening its technology stack.
It also plans to expand its global partner ecosystem and drive commercial growth across North America, LATAM, Europe, Asia-Pacific, and emerging markets.
CARPL.ai aims to expand beyond medical imaging into pathology, genomics, and general medicine.

Medical imaging generates more than 80% of healthcare data, but AI adoption remains fragmented despite over 1,000 FDA-cleared radiology applications.
The Indian healthtech market is projected to become a $37 Bn opportunity by 2030.
CARPL.ai was part of the YourStory Tech30 cohort of 2022.

CARPL.ai is a healthtech SaaS platform that enables hospitals and radiologists to deploy, manage, and monitor multiple medical imaging AI applications through a single interface.
It is a vendor-neutral platform, allowing healthcare providers to build, test, deploy, and monitor AI applications used in radiology.
The platform hosts an AI marketplace with more than 300 AI applications from over 100 vendors and partners.
It integrates deeply with leading PACS (Picture Archiving and Communication System) providers, which store, retrieve, manage, and share medical images like X-rays and MRIs.
Customers include 30 hospitals and medical centres across North America, Latin America, Europe, UK, Middle East, India, Southeast Asia, and Australia.
Notable customers include the Singapore government, Clinton Health Access Initiative in India, I-MED Radiology Network (Australia), RadNet (US), Fleury (Brazil), and Medica (UK).
The company serves four of the five largest private radiology groups globally and government health systems in Brazil, India, Singapore, Spain, and UAE.
It has 80 employees and offices in Delhi NCR (headquarters), San Francisco Bay Area, and Singapore.

Expand beyond medical imaging into pathology, genomics, and general medicine.
Strengthen technology stack and expand global partner ecosystem.
Drive commercial growth across North America, LATAM, Europe, Asia-Pacific, and emerging markets.

International Finance Corporation (lead) — Private sector arm of the World Bank Group.
Stellaris Venture Partners (participated) — Existing investor; previously led CARPL.ai's seed round.

Product: Vendor-neutral SaaS platform that enables hospitals to build, test, deploy and monitor AI applications for radiology
Customers: Hospitals, radiologists and medical centers seeking to deploy medical imaging AI applications
How it makes money: B2B SaaS marketplace hosting 300+ AI applications from 100+ vendors accessible through single platform
What sets it apart: Single software interface eliminating need for separate APIs and integrations for each AI vendor
Operations: Serves 30 hospitals across North America, Europe, Middle East, India, Southeast Asia, Australia and Latin America